dsm-firmenich completes the divestiture of its Jiangshan vitamin C plant in China

Published: 8-Mar-2024
Finance

Financial details of the transaction were not disclosed

dsm-firmenich has announced the successful sale and transfer of its 100% equity interest in DSM Jiangshan Pharmaceutical Co., Ltd to Jingjiang Cosfocus Health Technology Co., Ltd.

dsm-firmenich announced on 28 June 2023 it was exploring a range of options for the Jiangshan vitamin C plant in Jinjiang, China.
 

  • Companies:
  • dsm-firmenich
See more

You may also like

Finance

dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

Read more
The company has repurchased 500,000 shares for a total consideration of €51.6m

Trending Articles

  1. Overcoming the dairy dilemma: Valio sees an increase in net sales With many hurdles to overcome, Valio's net profits grew from 2022 by 2%
  2. Arla Foods Ingredients acquires Volac’s Whey Nutrition business The acquisition would allow Arla to utilise Volac's Felinfach site as a global production hub for its performance, health and food sectors
  3. Nutraceuticals: a major revenue opportunity for pharma companies There isn’t a single industry that hasn’t been affected by global economic disruptions in recent years. When searching for new revenue opportunities to mitigate these effects, many pharmaceutical companies are turning to nutraceuticals, reports Matevž Ambrožič, Marketing and PR Director at PharmaLinea
  4. Chinese consortium IVC to acquire Nutra Manufacturing from GNC International Vitamin Corporation will pay US$176 million for supplements production facilities in the US
  5. Kuehnle AgroSystems files patent for algae strain for astaxanthin Dr Adelheid Kuehnle, KAS founder and CEO, says the naturally sourced yellow strain is non-mutagenised and non-genetically engineered

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Finance

dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

The company has repurchased 500,000 shares for a total consideration of €51.6m
Ingredients

dsm-firmenich announces repurchase of 1.5m shares to cover share plans

The repurchasing of shares equates to around €156m
Finance

dsm-firmenich to separate out Animal Nutrition & Health business from the Group

The company will be placing a full focus on nutrition, health and beauty
Finance

dsm-firmenich completes voluntary cash offer for DSM shares

4,163,287 shares, representing approximately 2.4% of the company’s share availability, have been tendered to the company under the voluntary tender offer
Finance

dsm-firmenich makes voluntary cash offer for DSM shares

DSM-Firmenich AG and DSM BV (DSM) announce that the remaining holders of DSM ordinary shares will have the opportunity to sell their DSM ordinary shares to dsm-firmenich through the voluntary tender offer launched by dsm-firmenich
Ingredients

Indena and dsm-firmenich join forces to pioneer a new "age of nature"

The two companies have announced a collaboration at the first day of SupplySide West 2023 to pioneer a new “age of nature” through selected market-inspired botanical solutions for human health
Ingredients

DSM-Firmenich announces placement of 6.7 million shares through accelerated bookbuild

The c. 6.7 million existing DSM-Firmenich ordinary shares through an accelerated bookbuild offers for a total amount of €733 million
Subscribe now